# Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19

> **NCT04438057** · PHASE2 · COMPLETED · sponsor: **Metro Infectious Disease Consultants** · enrollment: 103 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** CCP

## Key facts

- **NCT ID:** NCT04438057
- **Lead sponsor:** Metro Infectious Disease Consultants
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-12
- **Primary completion:** 2020-08-12
- **Final completion:** 2021-08-12
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2022-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04438057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04438057, "Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04438057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*